Analabs Resources BhdXKLS:7083 70 EBITDA Margin % is 80.79% as of Jan. 2026, which is 302% above its 10-year median of 20.11. GuruFocus rates XKLS:7083 with a GF Score™ of 70/100 and a GF Value™ of RM1.39 (Modestly Overvalued). The stock has 11 warning signs investors should review. Among 1,585 Chemicals companies, Analabs Resources Bhd ranks better than 98.55% on this metric.
Analabs Resources Bhd (XKLS:7083) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Analabs Resources Bhd EBITDA Margin % Related Terms
Analabs Resources Bhd EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Analabs Resources Bhd's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:7083 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Analabs Resources Bhd's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Analabs Resources Bhd EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Analabs Resources Bhd's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Analabs Resources Bhd's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Analabs Resources Bhd (XKLS:7083) has a EBITDA Margin % of 80.79% as of Jan. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Analabs Resources Bhd and its competitors. This is 302% above median its historical median of 20.11. Over the past decade, Analabs Resources Bhd's EBITDA Margin % has ranged from 10.24 to 56.56. According to the industry distribution chart, Analabs Resources Bhd ranks #23 out of 1585 companies in the Chemicals industry, placing it in the top 1.5%.
Is Analabs Resources Bhd's EBITDA Margin % too high?
Analabs Resources Bhd's current EBITDA Margin % of 80.79% is 302% above median its 10-year median of 20.11. Over the past 10 years, this metric has ranged from a low of 10.24 to a high of 56.56. The Chemicals industry median EBITDA Margin % is 9.63. Analabs Resources Bhd's value of 80.79% is 738.9% above this industry median. Based on the distribution chart, Analabs Resources Bhd ranks #23 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Analabs Resources Bhd has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Analabs Resources Bhd's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Analabs Resources Bhd ranks #23 out of 1585 companies for EBITDA Margin %. This places Analabs Resources Bhd in the top 2% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.63. Analabs Resources Bhd's value of 80.79% is 738.9% above this benchmark. Historically, Analabs Resources Bhd's own EBITDA Margin % has ranged from 10.24 to 56.56 over the past decade. While the company's 10-year median is 20.11 vs. the industry median of 9.63, Analabs Resources Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Analabs Resources Bhd's current EBITDA Margin % of 80.79% is 738.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Analabs Resources Bhd and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Analabs Resources Bhd's current EBITDA Margin % is 80.79%, which is 302% above median its own 10-year median of 20.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Analabs Resources Bhd stock overvalued right now?
Based on GuruFocus' analysis, Analabs Resources Bhd (XKLS:7083) is currently considered Modestly Overvalued. The stock's GF Value™ is RM1.39, compared to a current price of RM1.70 — trading 22.3% above its estimated fair value. The current EBITDA Margin % is 80.79%, which is 302% above median its 10-year median of 20.11 and 738.9% above the Chemicals industry median of 9.63. Analabs Resources Bhd's overall GF Score™ is 70/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Analabs Resources Bhd (XKLS:7083), the current EBITDA Margin % is 80.79% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Analabs Resources Bhd (XKLS:7083) Overvalued in 2026?
Based on GuruFocus' analysis, Analabs Resources Bhd stock appears to be overvalued.
The current stock price of RM1.70 is trading 22.3% above its estimated GF Value™ of RM1.39.
GuruFocus considers Analabs Resources Bhd to be Modestly Overvalued.
Key valuation signals for XKLS:7083:
EBITDA Margin %: 80.79% (302% above median its 10-year median of 20.11)
GF Value™: RM1.39 vs. price of RM1.70 (22.3% above fair value)
Industry Position: 738.9% above the Chemicals median (#23 of 1585)
No single metric tells the full story. See the XKLS:7083 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Analabs Resources Bhd is a Malaysia-based company engaged in the businesses of investment holding and the provision of management services. It has five business segments, which include: Manufacturing, formulation, and sale of resin, chemicals, and building materials; Recovery and sale of recycled products; Contract work, pipe laying, and rehabilitation; Culture and sale of prawns; Investment holding and property letting, and asset and portfolio management. The company earns the majority of its revenue from the manufacturing, formulation, and sale of resin, chemicals, and building materials. Geographically, the company derives its maximum revenue from Malaysia and the rest from Singapore.
70GF Score
Get the complete analysis for XKLS:7083
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7083 has been successfully added to your 
